According to estimates by the World Health Organisation, COPD ranks third among the leading causes of death globally.

70% of Chronic Obstructive Pulmonary Disease (COPD) cases go undiagnosed. Now, a study led by Hospital del Mar and the Hospital del MResearch Institute has validated ten metabolites that are altered ...

Early detection and innovative biologic treatment can prevent hospitalizations, improve quality of life, and extend the ...

A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has highlighted recent advances in ...

Examining a patient for common or complex pulmonary issues in a primary care setting takes time and expertise — physicians need to ask about symptoms and medical history and determine which tests to ...

COPD remains one of India's most underdiagnosed lung diseases, with millions noticing symptoms only after serious damage.

Patients in the UK will be able to access cutting-edge testing for Chronic Obstructive Pulmonary Disease (COPD) - the UK’s sixth biggest killer - as the NHS rolls out faster, more accessible ...

According to the World Health Organisation, chronic obstructive pulmonary disease is the fourth-leading cause of death ...

COPD is a group of progressive lung diseases that includes emphysema and chronic bronchitis. Despite affecting an estimated 32 million people in the United States, as many as half are unaware they ...

A GSK drug that targets a pathway behind the lung inflammation in chronic obstructive pulmonary disease, or COPD, has won a long-awaited FDA approval, positioning the biologic medicine to reach ...